• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   1990-1999  
Title Created Date
Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells 01 April 2026
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo 20 June 2025
Retinoic acid receptor alpha mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells 24 March 2025
Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines 21 March 2025
Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis 19 March 2024
A review of the evidence supporting melatonin's role as an antioxidant 10 December 2023
Molecular biology of somatostatin receptor subtypes 23 June 2023
1,25-Dihydroxyvitamin D3 induces programmed cell death in a rat glioma cell line 31 May 2023
Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone 13 April 2023
Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma 07 April 2023
Display # 

Page 1 of 60

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Search

Follow us...

Latest

  • Prolactin inhibitors in oncology
  • Effects of melatonin and vitamin E on oxidative-antioxidative status in rats exposed to irradiation
  • Protective effects of melatonin on the ionizing radiation induced DNA damage in the rat brain
  • Somatostatin in oncology, the overlooked evidences
  • Melatonin and breast cancer: Evidences from preclinical and human studies
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Melatonin protects rat liver against irradiation-induced oxidative injury
  • The Intricate Relationship between Melatonin and Breast Cancer: A Short Review
  • A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer
  • Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis
  • Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies
  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
  • 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
  • The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy
  • Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
  • Melatonin and Cancer Hallmarks
  • BREAST CANCER AND PROLACTIN: A LIFETIME RELATIONSHIP
  • Prolactin involvement in breast cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer